Also trades as: 4516.T (JPX) · $vol 8M · NPNKF (OTC) · $vol 0M

$5.40

-0.06 (-1.10%)

Weekly Expected Move ±7.5%

$5 $5 $5 $6 $6

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 45 · $1.5B mcap · 63M float · 0.0001% daily turnover · Short 80% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$181.1B +13.0% ▲

5Y CAGR: +8.2%

Gross Profit

$120.1B +10.1% ▲

5Y CAGR: +10.8%

Operating Income

$35.0B -4.7% ▼

5Y CAGR: +6.0%

Net Income

$31.5B -3.2% ▼

5Y CAGR: +10.0%

EPS (Diluted)

$116.64 -3.5% ▼

5Y CAGR: +10.0%

EBITDA

$42.1B +1.4% ▲

5Y CAGR: +5.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$137.5B	$144.2B	$148.3B	$160.2B	$181.1B
YoY Growth	+12.8%	+4.9%	+2.8%	+8.1%	+13.0%
Cost of Revenue	$50.2B	$56.0B	$51.2B	$51.1B	$60.9B
Gross Profit	$87.3B	$88.2B	$97.0B	$109.1B	$120.1B
Gross Margin	63.5%	61.2%	65.4%	68.1%	66.4%
R&D Expenses	$22.9B	$24.1B	$31.7B	$34.3B	$38.9B
SG&A Expenses	$31.3B	$34.8B	$34.0B	$38.0B	$46.2B
Operating Expenses	$54.3B	$58.1B	$65.6B	$72.4B	$85.1B
Operating Income	$32.9B	$30.0B	$31.4B	$36.8B	$35.0B
Operating Margin	24.0%	20.8%	21.2%	22.9%	19.3%
Interest Expense	$119M	$136M	$329M	$145M	$176M
Income Before Tax	$33.3B	$30.5B	$33.6B	$36.1B	$38.7B
Tax Expense	$8.3B	$7.7B	$7.8B	$3.6B	$7.1B
Net Income	$25.0B	$22.8B	$25.9B	$32.6B	$31.5B
Net Margin	18.2%	15.8%	17.4%	20.3%	17.4%
EPS (Diluted)	$92.74	$84.68	$95.96	$120.82	$116.64
EBITDA	$38.0B	$35.7B	$36.3B	$41.5B	$42.1B
Shares Outstanding	269M	269M	269M	269M	270M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$39.1B	$40.2B	$42.0B	$38.9B	$39.5B	$40.8B	$48.3B	$44.4B
Cost of Revenue	$12.6B	$12.3B	$13.9B	$12.3B	$12.7B	$12.9B	$17.0B	$15.7B
Gross Profit	$26.5B	$27.9B	$28.1B	$26.6B	$26.9B	$27.9B	$31.4B	$28.7B
Gross Margin	67.7%	69.4%	67.0%	68.4%	68.0%	68.4%	64.9%	64.6%
R&D Expenses	$7.5B	$9.2B	$6.8B	$10.8B	$6.2B	$8.6B	$8.5B	$13.9B
SG&A Expenses	$9.2B	$8.8B	$9.5B	$10.4B	$10.0B	$10.5B	$11.6B	$12.1B
Operating Expenses	$16.7B	$18.0B	$16.3B	$21.2B	$16.8B	$19.1B	$20.1B	$26.0B
Operating Income	$9.8B	$9.9B	$11.8B	$5.4B	$10.1B	$8.8B	$11.3B	$2.7B
Operating Margin	25.0%	24.5%	28.0%	13.8%	25.5%	21.5%	23.3%	6.1%
Interest Expense	$31M	$1M	$0	$367K	$318K	$56M	$19M	$47M
Income Before Tax	$11.4B	$6.8B	$15.2B	$2.7B	$10.5B	$9.7B	$13.4B	$3.3B
Tax Expense	$1.1B	$678M	$3.1B	-$1.3B	$2.2B	$2.1B	$3.2B	-$654M
Net Income	$10.3B	$6.1B	$12.2B	$4.0B	$8.3B	$7.6B	$10.3B	$3.9B
Net Margin	26.2%	15.2%	29.0%	10.3%	20.9%	18.7%	21.2%	8.9%
EPS (Diluted)	$38.10	$22.67	$45.19	$14.86	$30.63	$28.50	$37.65	$14.59
EBITDA	$12.9B	$8.3B	$16.4B	$4.2B	$11.7B	$11.4B	$13.0B	$4.5B
Shares Outstanding	269M	269M	270M	270M	270M	270M	270M	271M

NPPNY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet